D. Cashion

发表

A highly selective and specific PET tracer for imaging of tau pathologies.

Wei Zhang, H. Kolb, Wei Zhang, 2012, Journal of Alzheimer's disease : JAD.

Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphatase.

M. Erion, Q. Dang, S. Kasibhatla, 2011, Journal of medicinal chemistry.

Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy.

G. Fenalti, L. LeBrun, Dan Zhu, 2019, Journal of medicinal chemistry.

An unexpected cyclization discovered during the synthesis of 8-substituted purines from a 4,5-diaminopyrimidine

M. Erion, Q. Dang, R. Rydzewski, 2008 .

Chiral recognition between a substituted cyclooctatetraene dianion and a half crown ether substituted with ibuprofen.

D. Cashion, C. D. Stevenson, 2000, The Journal of organic chemistry.

The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen.

L. LeBrun, Dan Zhu, B. Pagarigan, 2017, Journal of medicinal chemistry.

Hit-to-Lead Optimization and Discovery of 5-((5-([1,1'-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903): A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein Kinase.

Margaret S. Wu, Q. Dang, D. Mackenna, 2017, Journal of medicinal chemistry.

Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005.

E. Hur, Lisa Morrison, B. Bennett, 2021, Journal of medicinal chemistry.

Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors.

M. Erion, Q. Dang, S. Kasibhatla, 2008, Journal of medicinal chemistry.

Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity.

L. LeBrun, T. Tran, K. Leftheris, 2021, Journal of medicinal chemistry.